| abstract |
The invention relates to novel benzimidazoles of general formula (1), wherein R a to R c, A, Ar and B have the meanings given in Claim 1, to tautomers, stereoisomers, mixtures and pro-drugs thereof, derivatives thereof containing a group which is negatively charged under physiological conditions in place of a carboxy group, and salts thereof, especially their physiologically compatible salts with inorganic or organic acids or bases with useful properties. The compounds of general formula (I) above wherein R c represents a cyano group are useful intermediate products for the production of the other compounds of general formula (I) and the compounds of general formula (I) wherein R c represents one of the amidino groups cited in Claim I have useful pharmacological properties, especially an antithrombotic effect. |